Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Vaccinex Inc (VCNX)

3.97   -0.25 (-5.92%) 02-25 11:41
Open: 4.1 Pre. Close: 4.22
High: 4.21 Low: 3.8
Volume: 1,408,404 Market Cap: 89M
Vaccinex, Inc. is a clinical-stage biotechnology company, which engages in the development of targeted biotherapeutics to treat serious diseases and conditions with unmet medical needs, including cancer, neurodegenerative diseases, and autoimmune disorders. The company is headquartered in Rochester, New York and currently employs 44 full-time employees. The firm is focused on providing treatments for serious diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. The company provides SEMA4D antibody platform, which is focused on developing its lead product candidate VX15/2503 (VX15) for the treatment of non-small cell lung cancer, NSCLC, osteosarcoma, melanoma and Huntington’s disease. The company also provides ActiveMAb antibody discovery platform, a human antibody discovery platform used for expressing large and diverse libraries of high affinity, full-length human monoclonal antibodies on the surface of vaccinia, a mammalian virus. Its product candidate VX5 is in preclinical development for the treatment of multiple sclerosis and potentially for other autoimmune disorders.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 4.633 - 4.655 4.655 - 4.676
Low: 3.97 - 3.992 3.992 - 4.014
Close: 4.182 - 4.218 4.218 - 4.253

Technical analysis

as of: 2021-02-25 11:18:17 AM
Overall:       
Stoxline posted a SELL today, downgraded from higher rating. Downward movement to be expected.
Target: Six months: 7.93     One year: 11.17
Support: Support1: 2.30    Support2: 1.91
Resistance: Resistance1: 6.79    Resistance2: 9.56
Pivot: 3.58
Moving Average: MA(5): 4.44     MA(20): 3.34
MA(100): 2.34     MA(250): 3.60
MACD: MACD(12,26): 0.44     Signal(9): 0.36
Stochastic oscillator: %K(14,3): 20.55     %D(3): 26.55
RSI: RSI(14): 58.32
52-week: High: 9.56  Low: 1.63  Change(%): -25.6
Average Vol(K): 3-Month: 555281  10-Days: 3032053

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.
VCNX has closed below upper band by 35.2%. Bollinger Bands are 159.7% wider than normal. The large width of the bands suggest high volatility as compared to VCNX's normal range. The bands have been in this wide range for 4 bars. This is a sign that the current trend might continue.

Headline News

Wed, 24 Feb 2021
Should Biotechnology Stock Vaccinex Inc (VCNX) Be in Your Portfolio Wednesday? - InvestorsObserver

Tue, 23 Feb 2021
Premarket Mover: Vaccinex Inc (VCNX) Down 11.94% - InvestorsObserver

Mon, 22 Feb 2021
Vaccinex Announces Licensing of Anti-CCR8 Antibody to Surface Oncology - GlobeNewswire

Fri, 19 Feb 2021
Mid-afternoon market update: S&P 500 turns negative; Vaccinex (VCNX Stock) shares spike higher - FXStreet

Fri, 19 Feb 2021
Do Traders View Vaccinex Inc (VCNX) Stock's Current Trend Positively? - InvestorsObserver

Fri, 19 Feb 2021
VCNX Stock: 11 Things to Know About Vaccinex and the Deals That Have Shares Soaring - InvestorPlace

Financial Analysis

Growth n/a
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability n/a
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency n/a
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency n/a
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Underperform Discounted cash flow: Outperform
Return on Assets: Underperform Price to Earnings: Underperform
Return on Equity: Outperform Debt to Equity: Underperform
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 22
Shares Float (M) 9
% Held by Insiders 18.40
% Held by Institutions 50.40
Shares Short (K) 177
Shares Short P. Month (K) 257

Stock Financials

EPS -1.702
EPS Est This Year
EPS Est Next Year
Book Value (p.s.) -0.900
Profit Margin
Operating Margin -4572.96
Return on Assets (ttm) -121.0
Return on Equity (ttm) -748.4
Qtrly Rev. Growth 54.7
Gross Profit (p.s.) 0.014
Sales Per Share 0.028
EBITDA (p.s.) -1.263
Qtrly Earnings Growth
Operating Cash Flow (M) -28
Levered Free Cash Flow (M) -18

Stock Valuations

PE Ratio -2.34
PEG Ratio
Price to Book value -4.42
Price to Sales 142.58
Price to Cash Flow -3.17

Stock Dividends

Dividend
Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2020 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.